November 15, 2021
The Issue
Accurate diagnosis requires the right mix of affordable and high-quality technology and health system efficiency. Not only is it important to choose the right technologies for each healthcare setting, there are also several essential health services that need to be functioning around the laboratory for testing to be delivered effectively.
Many countries are still working to establish both the technology infrastructure and the associated health systems required. As such, testing remains a critical gap for many diseases.
The COVID-19 pandemic brought this into sharp focus. Providing testing rapidly became an enormous priority for countries, not only for individual patient care, but also to track and manage spread of the disease for pandemic control.
CHAI's Approach
CHAI’s Global Diagnostics Team works closely with country partners and other agencies to improve access to high-quality, affordable diagnostics for COVID-19, HIV, cervical cancer, tuberculosis (TB), malaria, hepatitis, diabetes, and overall diagnostics delivery services in low- and middle-income countries. CHAI takes a patient-centric and holistic approach that focuses on introducing innovative diagnostic technologies and delivery systems that are proven through evidence generation, catalytic adoption, and scale-up by national governments.
CHAI helps establish the conditions to support high-quality diagnostic systems, especially for primary health care. We work closely with government partners to secure buy-in and support, updating policies and strategies, establishing supply chain and training systems, and activating and expanding testing capacity. We also help build diagnostic networks that maximize testing coverage and referral to care and reduce costs. Our focus is on accelerating access to high-quality and affordable diagnostics through coordinated engagement with both the supply and demand sides of the market.
Results
120M
affordable high-quality COVID-19 rapid antigen tests made available for LMICs
20+
countries helped with introducing and scaling-up rapid point-of-care PCR-based tests for HIV, TB, hepatitis, and COVID-19
US$1
lower pricing negotiated for dual HIV and syphilis rapid tests
<$10
negotiated price for HIV viral load in low and middle-income countries, saving more than $150M
Our Work
Join the Team
CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses.
View All CHAI Positions View Program Positions
Join the Team
CHAI is looking for dynamic and self-motivated individuals who are committed to strengthening health systems around the world and expanding access to care and treatment of HIV/AIDS, malaria, and other illnesses.
View All CHAI Positions View Program Positions